Researchers at Stanford University and Emory University have launched a nationwide initiative to monitor monkeypox, COVID-19, and other infectious diseases in communities by measuring viral genetic material in wastewater. ...
Aug 8, 2022
0
25
Viruses that cause respiratory diseases like the flu and COVID-19 can lead to mild to severe symptoms within the first few weeks of infection. These symptoms typically resolve within a few more weeks, sometimes with the help ...
Aug 5, 2022
0
16
President Joe Biden has plenty of company as he experiences a case of rebound COVID-19 after completing a course of the antiviral medication Paxlovid.
Aug 3, 2022
1
6
Scientists believe natural-killer cells in the liver may explain why liver transplant patients typically require less treatment with immunosuppressant drugs to prevent rejection than recipients of other organ transplants.
Jul 27, 2022
0
21
Insects like biting flies and cockroaches are not likely to spread the agent of COVID-19 to humans, according to a recently published article by Texas A&M AgriLife Research scientists.
Jul 22, 2022
0
40
Innate immunity is activated when the pattern recognition receptors (PRRs) recognize pathogen-associated molecular patterns (PAMPs). A research team from Kanazawa University has shown that a liver-derived secretory protein ...
Jul 15, 2022
0
11
In a case study, scientists of the German Center for Infection Research (DZIF) and the University Medical Center Hamburg-Eppendorf investigated the T-cell response of a cancer patient, who was suffering from prolonged COVID-19. ...
Jul 14, 2022
0
30
For health care providers who may be caring for Ukrainians displaced by the war, a new analysis published in CMAJ (Canadian Medical Association Journal) provides an overview of health and clinical considerations in this population. ...
Jul 11, 2022
0
2
By comparing the neutralization capacity induced by the different variants of SARS-CoV-2, a team from the UNIGE and the HUG reveals the exceptional capacity of omicron to evade our immunity.
Jul 6, 2022
0
116
The omicron subvariants BA.1 and BA.2 of SARS-CoV-2 have dominated the COVID-19 pandemic in early 2022. In many countries, these viruses are now outcompeted by emerging subvariants, with BA.5 being responsible for the current ...
Jul 1, 2022
0
149
